p.126 抽出テキスト
Michael A. Borger (Germany), Sergio Buccheri (Sweden), Borja Ibanez (Spain), Lars Køber (Denmark), Konstantinos C. Koskinas (Switzerland), John William McEvoy (Ireland), Borislava Mihaylova (United Kingdom), Richard Mindham (United Kingdom), Lis Neubeck (United Kingdom), Jens Cosedis Nielsen (Denmark), Agnes A. Pasquet (Belgium), Amina Rakisheva (Kazakhstan), Bianca Rocca (Italy), Xavier Rossello (Spain), Ilonca Vaartjes (Netherlands), Christiaan Vrints (Belgium), Adam Witkowski (Poland), and Katja Zeppenfeld (Netherlands). 20 References 1. van Kuijk JP, Flu WJ, Welten GM, Hoeks SE, Chonchol M, Vidakovic R, et al. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J 2010;31:992–9. https://doi.org/10.1093/eurheartj/ ehp553 2. Dolmaci OB, El Mathari S, Driessen AHG, Klautz RJM, Poelmann RE, Lindeman JHN, et al. Are thoracic aortic aneurysm patients at increased risk for cardiovascular diseases? J Clin Med 2023;12:272. https://doi.org/10.3390/jcm12010272 3. Tully L, Gianos E, Vani A, Guo Y, Balakrishnan R, Schwartzbard A, et al. Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention. Am Heart J 2014;168:310–6.e3. https://doi.org/10.1016/j.ahj.2014.05.011 4. Saratzis A, Jaspers NEM, Gwilym B, Thomas O, Tsui A, Lefroy R, et al. Observational study of the medical management of patients with peripheral artery disease. Br J Surg 2019;106:1168–77. https://doi.org/10.1002/bjs.11214 5. McDermott MM, Mandapat AL, Moates A, Albay M, Chiou E, Celic L, et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med 2003;163:2157–62. https://doi. org/10.1001/archinte.163.18.2157 6. Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis 2022;81:1654–60. https://doi.org/10.1136/ard-2022-223482 7. Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2020;79:19–30. https://doi.org/10.1136/annrheumdis-2019-215672 8. Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 2022;81:1647–53. https://doi.org/10.1136/ard-2022-223480 9. Stone JR, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L, et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 2015;24:267–78. https://doi.org/10. 1016/j.carpath.2015.05.001 10. Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019. Lancet 2020;396:1204–22. https://doi.org/10.1016/S0140- 6736(20)30925-9 11. Lin J, Chen Y, Jiang N, Li Z, Xu S. Burden of peripheral artery disease and its attributable risk factors in 204 countries and territories from 1990 to 2019. Front Cardiovasc Med 2022;9:868370. https://doi.org/10.3389/fcvm.2022.868370 12. GBD 2019 Peripheral Artery Disease Collaborators. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019. Lancet Glob Health 2023;11:e1553–65. https://doi.org/10.1016/ S2214-109X(23)00355-8 13. Liu W, Yang C, Chen, Lei F, Qin J-J, Liu H, et al. Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: results from the Global Burden of Disease study 2019. Atherosclerosis 2022;347:17–27. https://doi.org/10.1016/j.atherosclerosis.2022.03.002 14. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 2020;76:2982–3021. https://doi.org/10.1016/j. jacc.2020.11.010 15. Pu L, Wang L, Zhang R, Zhao T, Jiang Y, Han L. Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke 2023;54:1330–9. https://doi.org/10.1161/STROKEAHA.122.040073 16. Summers KL, Kerut EK, Sheahan CM, Sheahan MG, III. Evaluating the prevalence of abdominal aortic aneurysms in the United States through a national screening database. J Vasc Surg 2021;73:61–8. https://doi.org10.1016/j.jvs.2020.03.046 17. Behrendt CA, Thomalla G, Rimmele DL, Petersen EL, Twerenbold R, Debus ES, et al. Editor’s choice—prevalence of peripheral arterial disease, abdominal aortic aneurysm, and risk factors in the Hamburg city health study: a cross sectional analysis. Eur J Vasc Endovasc Surg 2023;65:590–8. https://doi.org/10.1016/j.ejvs.2023.01.002 18. Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E, et al. Risk prediction tools in cardiovascular disease prevention: a report from the ESC Prevention of CVD programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur Heart J Acute Cardiovasc Care 2020;9: 522–32. https://doi.org/10.1177/2048872619858285 19. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42:3227–337. https://doi.org/10.1093/eurheartj/ehab484 20. Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res 2021;128:1818–32. https://doi.org/10.1161/CIRCRESAHA.121. 318535 21. Pabon M, Cheng S, Altin SE, Sethi SS, Nelson MD, Moreau KL, et al. Sex differences in peripheral artery disease. Circ Res 2022;130:496–511. https://doi.org/10.1161/ CIRCRESAHA.121.320702 22. Khawaja T, Janus SE, Tashtish N, Janko M, Baeza C, Gilkeson R, et al. Prevalence of thoracic aortic aneurysm in patients referred for no/low-charge coronary artery calcium scoring: insights from the CLARIFY registry. Am J Prev Cardiol 2022;12:100378. https://doi.org/10.1016/j.ajpc.2022.100378 23. Obel LM, Diederichsen AC, Steffensen FH, Frost L, Lambrechtsen J, Busk M, et al. Population-based risk factors for ascending, arch, descending, and abdominal aortic dilations for 60-74-year-old individuals. J Am Coll Cardiol 2021;78:201–11. https://doi.org/ 10.1016/j.jacc.2021.04.094 24. Bossone E, Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nat Rev Cardiol 2021;18:331–48. https://doi.org/ 10.1038/s41569-020-00472-6 25. Verhagen JMA, Kempers M, Cozijnsen L, Bouma BJ, Duijnhouwer AL, Post JG, et al. Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first-degree relatives. Int J Cardiol 2018;258:243–8. https:// doi.org/10.1016/j.ijcard.2018.01.145 26. Burger PM, Pradhan AD, Dorresteijn JAN, Koudstaal S, Teraa M, de Borst GJ, et al. C-reactive protein and risk of cardiovascular events and mortality in patients with various cardiovascular disease locations. Am J Cardiol 2023;197:13–23. https://doi.org/10. 1016/j.amjcard.2023.03.025 27. Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med 2020;383:1838–47. https://doi. org/10.1056/NEJMoa2021372 28. Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 2019;381: 2497–505. https://doi.org/10.1056/NEJMoa1912388 29. Parkkila K, Kiviniemi A, Tulppo M, Perkiömäki J, Kesäniemi YA, Ukkola O. Carotid and femoral bruits as cardiovascular risk indicators in a middle-aged Finnish population: a 20-year prospective study. PLoS One 2022;17:e0278901. https://doi.org/10.1371/ journal.pone.0278901 30. Pickett CA, Jackson JL, Hemann BA, Atwood JE. Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet 2008; 371:1587–94. https://doi.org/10.1016/s0140-6736(08)60691-1 31. Charry D, Gouskova N, Meyer ML, Ring K, Nambi V, Heiss G, et al. Arterial stiffness and contralateral differences in blood pressure: the Atherosclerosis Risk in Communities (ARIC) study. J Clin Hypertens (Greenwich) 2022;24:878–84. https://doi. org/10.1111/jch.14493 32. Aboyans V, Criqui MH, McDermott MM, Allison MA, Denenberg JO, Shadman R, et al. The vital prognosis of subclavian stenosis. J Am Coll Cardiol 2007;49:1540–5. https://doi. org/10.1016/j.jacc.2006.09.055 33. Marcovina SM, Shapiro MD. Measurement of lipoprotein(a): a once in a lifetime opportunity. J Am Coll Cardiol 2022;79:629–31. https://doi.org/10.1016/j.jacc.2021.11. 053 34. Arndt H, Nordanstig J, Bertges DJ, Budtz-Lilly J, Venermo M, Espada CL, et al. A Delphi consensus on patient reported outcomes for registries and trials including patients with intermittent claudication: recommendations and reporting standard. Eur J Vasc Endovasc Surg 2022;64:526–33. https://doi.org/10.1016/j.ejvs.2022.08.011 35. Rymer JA, Narcisse D, Cosiano M, Tanaka J, McDermott MM, Treat-Jacobson DJ, et al. Patient-reported outcome measures in symptomatic, non-limb-threatening peripheral artery disease: a state-of-the-art review. Circ Cardiovasc Interv 2022;15:e011320. https://doi.org/10.1161/circinterventions.121.011320 36. Raja A, Spertus J, Yeh RW, Secemsky EA. Assessing health-related quality of life among patients with peripheral artery disease: a review of the literature and focus on patientreported outcome measures. Vasc Med 2021;26:317–25. https://doi.org/10.1177/ 1358863x20977016 37. Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, et al. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association. Circulation 2019;139:e10–33. https:// doi.org/10.1161/cir.0000000000000623 38. Poku E, Duncan R, Keetharuth A, Essat M, Phillips P, Woods HB, et al. Patient-reported outcome measures in patients with peripheral arterial disease: a systematic review of ESC Guidelines 3663 Downloaded from academic.oup.com/eurheartj/article/45/36/3538/7738955 by guest on 07 October 2026